These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 14570772

  • 1. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.
    Chatterjee P, Franklin MR.
    Drug Metab Dispos; 2003 Nov; 31(11):1391-7. PubMed ID: 14570772
    [Abstract] [Full Text] [Related]

  • 2. Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects.
    McDonald MG, Tian DD, Thummel KE, Paine MF, Rettie AE.
    Drug Metab Dispos; 2020 Oct; 48(10):1018-1027. PubMed ID: 32591416
    [Abstract] [Full Text] [Related]

  • 3. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS, Black SR, Patel PR, So J, Mathews JM.
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [Abstract] [Full Text] [Related]

  • 4. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
    Ma B, Prueksaritanont T, Lin JH.
    Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
    [Abstract] [Full Text] [Related]

  • 5. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M, Suzuki H, Komiya I.
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate.
    Kim JY, Baek M, Lee S, Kim SO, Dong MS, Kim BR, Kim DH.
    Drug Metab Dispos; 2001 Dec; 29(12):1555-60. PubMed ID: 11717174
    [Abstract] [Full Text] [Related]

  • 7. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT, Chang YW, Lan SJ, Yeh TK.
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
    Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T.
    Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes.
    Kim KA, Park JY.
    Drug Metab Dispos; 2003 Sep; 31(9):1090-2. PubMed ID: 12920163
    [Abstract] [Full Text] [Related]

  • 10. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF, Don MJ, Jan WC, Wang SY, Ho LK, Chen CF.
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.
    Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S.
    Life Sci; 2004 Apr 16; 74(22):2769-79. PubMed ID: 15043991
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
    McGinnity DF, Berry AJ, Kenny JR, Grime K, Riley RJ.
    Drug Metab Dispos; 2006 Aug 16; 34(8):1291-300. PubMed ID: 16679385
    [Abstract] [Full Text] [Related]

  • 13. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
    Witkamp RF, Nijmeijer SM, Monshouwer M, Van Miert AS.
    Drug Metab Dispos; 1995 May 16; 23(5):542-7. PubMed ID: 7587928
    [Abstract] [Full Text] [Related]

  • 14. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR, Hathaway LB.
    Drug Metab Dispos; 2008 Dec 16; 36(12):2539-46. PubMed ID: 18799803
    [Abstract] [Full Text] [Related]

  • 15. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J, Amin Usmani K, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Apr 15; 147(3):319-29. PubMed ID: 15135087
    [Abstract] [Full Text] [Related]

  • 16. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
    Pekthong D, Martin H, Abadie C, Bonet A, Heyd B, Mantion G, Richert L.
    J Ethnopharmacol; 2008 Feb 12; 115(3):432-40. PubMed ID: 18053665
    [Abstract] [Full Text] [Related]

  • 17. Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes.
    Kim JY, Lee S, Kim DH, Kim BR, Park R, Lee BM.
    J Toxicol Environ Health A; 2002 Mar 12; 65(5-6):373-81. PubMed ID: 11936218
    [Abstract] [Full Text] [Related]

  • 18. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
    Kitamura A, Mizuno Y, Natsui K, Yabuki M, Komuro S, Kanamaru H.
    Biopharm Drug Dispos; 2005 Mar 12; 26(2):59-65. PubMed ID: 15619261
    [Abstract] [Full Text] [Related]

  • 19. Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.
    Raner GM, Cornelious S, Moulick K, Wang Y, Mortenson A, Cech NB.
    Food Chem Toxicol; 2007 Dec 12; 45(12):2359-65. PubMed ID: 17658211
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.
    Liu KH, Kim MJ, Jeon BH, Shon JH, Cha IJ, Cho KH, Lee SS, Shin JG.
    J Clin Pharm Ther; 2006 Feb 12; 31(1):83-91. PubMed ID: 16476124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.